Skip to main content
Clinical Trials/CTRI/2024/07/070846
CTRI/2024/07/070846
Not yet recruiting
未知

Identify microbial and metabolic biomarkers for building gut profile of a.) Depression and b.) Irritable Bowel Syndrome - NI

MicrobioTx Health Private Limited0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
MicrobioTx Health Private Limited
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational

Investigators

Sponsor
MicrobioTx Health Private Limited

Eligibility Criteria

Inclusion Criteria

  • For depression subgroup \- Patients with mild\-moderate\-severe depression,
  • as defined by ICD\-11, classified on the basis of self\-reported responses to
  • The International Depression Questionnaire (IDQ)
  • 3\) For IBS subgroup \- Patients with IBS as per Rome III diagnostic criteria.
  • Rome III criteria for diagnosis of IBS is mentioned as below \-
  • A patient might have IBS if they recurrent abdominal pain or discomfort
  • for at least three days a month for the last three months, associated with
  • two or more of the following criteria:
  • ? Improvement with defecation
  • ? Onset associated with a change in frequency of stool

Exclusion Criteria

  • 1\. Any active illness, psychological and/or pathological condition or chronic
  • disease that would interfere with study participation in the opinion of the
  • Investigator.
  • 2\. Participants with a history of alcohol consumption exceeding 20 grams
  • per day (both male and female)
  • 3\. Participants taking immunosuppressants, tamoxifen, amiodarone and/or
  • perhexiline;
  • 4\. Participants who have taken antibiotics in the last 3 months
  • 5\. Type 2 diabetes mellitus on insulin, or other glucose lowering therapy (eg
  • GLP\-1 agonists, SGLT2\- inhibitors and DPP4 inhibitors)

Outcomes

Primary Outcomes

Not specified

Similar Trials